1. Home
  2. CYTK vs BE Comparison

CYTK vs BE Comparison

Compare CYTK & BE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • BE
  • Stock Information
  • Founded
  • CYTK 1997
  • BE 2001
  • Country
  • CYTK United States
  • BE United States
  • Employees
  • CYTK N/A
  • BE N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • BE Industrial Machinery/Components
  • Sector
  • CYTK Health Care
  • BE Energy
  • Exchange
  • CYTK Nasdaq
  • BE Nasdaq
  • Market Cap
  • CYTK 4.4B
  • BE 5.1B
  • IPO Year
  • CYTK 2004
  • BE 2018
  • Fundamental
  • Price
  • CYTK $38.62
  • BE $46.06
  • Analyst Decision
  • CYTK Buy
  • BE Buy
  • Analyst Count
  • CYTK 13
  • BE 17
  • Target Price
  • CYTK $71.58
  • BE $27.26
  • AVG Volume (30 Days)
  • CYTK 1.4M
  • BE 12.2M
  • Earning Date
  • CYTK 08-07-2025
  • BE 07-31-2025
  • Dividend Yield
  • CYTK N/A
  • BE N/A
  • EPS Growth
  • CYTK N/A
  • BE N/A
  • EPS
  • CYTK N/A
  • BE 0.10
  • Revenue
  • CYTK $85,738,000.00
  • BE $1,630,054,000.00
  • Revenue This Year
  • CYTK $27.08
  • BE $21.86
  • Revenue Next Year
  • CYTK $652.09
  • BE $21.05
  • P/E Ratio
  • CYTK N/A
  • BE $438.43
  • Revenue Growth
  • CYTK 2635.74
  • BE 22.72
  • 52 Week Low
  • CYTK $29.31
  • BE $9.02
  • 52 Week High
  • CYTK $59.39
  • BE $46.50
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 60.89
  • BE 76.13
  • Support Level
  • CYTK $32.89
  • BE $41.42
  • Resistance Level
  • CYTK $36.79
  • BE $46.50
  • Average True Range (ATR)
  • CYTK 1.73
  • BE 2.93
  • MACD
  • CYTK 0.15
  • BE 0.56
  • Stochastic Oscillator
  • CYTK 91.77
  • BE 82.05

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About BE Bloom Energy Corporation

Bloom Energy designs, manufactures, sells, and installs solid-oxide fuel cell systems ("Energy Servers") for on-site power generation. Bloom Energy Servers are fuel-flexible and can use natural gas, biogas, and hydrogen to create 24/7 electricity for stationary applications. In 2021, the company announced plans to leverage its technology and enter the electrolyzer market. Bloom primarily sells its systems in the United States and internationally.

Share on Social Networks: